CS545386A2 - Method of tertiary hydroxyalkylxanthine production - Google Patents

Method of tertiary hydroxyalkylxanthine production

Info

Publication number
CS545386A2
CS545386A2 CS865453A CS545386A CS545386A2 CS 545386 A2 CS545386 A2 CS 545386A2 CS 865453 A CS865453 A CS 865453A CS 545386 A CS545386 A CS 545386A CS 545386 A2 CS545386 A2 CS 545386A2
Authority
CS
Czechoslovakia
Prior art keywords
hydroxyalkylxanthine
tertiary
production
tertiary hydroxyalkylxanthine
hydroxyalkylxanthine production
Prior art date
Application number
CS865453A
Other languages
English (en)
Other versions
CS272766B2 (en
Inventor
Ulrich Dr Gebert
Ismahan Dr Okyayuz-Baklouti
Werner Dr Thorwart
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Priority to CS200789A priority Critical patent/CS272799B2/cs
Priority to CS200889A priority patent/CS272800B2/cs
Priority to CS200689A priority patent/CS272798B2/cs
Publication of CS545386A2 publication Critical patent/CS545386A2/cs
Publication of CS272766B2 publication Critical patent/CS272766B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
CS545386A 1985-07-19 1986-07-17 Method of tertiary hydroxyalkylxanthine production CS272766B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CS200789A CS272799B2 (en) 1985-07-19 1989-03-31 Method of teriary hydroxylxanthine production
CS200889A CS272800B2 (en) 1985-07-19 1989-03-31 Method of tertiary hydroxyalkylxantine production
CS200689A CS272798B2 (en) 1985-07-19 1989-03-31 Method of tertiaryhydroxyalkylanthine production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853525801 DE3525801A1 (de) 1985-07-19 1985-07-19 Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung

Publications (2)

Publication Number Publication Date
CS545386A2 true CS545386A2 (en) 1990-04-11
CS272766B2 CS272766B2 (en) 1991-02-12

Family

ID=6276182

Family Applications (1)

Application Number Title Priority Date Filing Date
CS545386A CS272766B2 (en) 1985-07-19 1986-07-17 Method of tertiary hydroxyalkylxanthine production

Country Status (33)

Country Link
US (1) US4833146A (cs)
EP (1) EP0268585B1 (cs)
JP (1) JPH0788382B2 (cs)
KR (1) KR950001019B1 (cs)
CN (1) CN1026112C (cs)
AR (1) AR244689A1 (cs)
AT (1) ATE53211T1 (cs)
AU (1) AU588350B2 (cs)
BG (1) BG60767B2 (cs)
CA (1) CA1262248A (cs)
CS (1) CS272766B2 (cs)
DD (1) DD261156A5 (cs)
DE (2) DE3525801A1 (cs)
DK (1) DK157867C (cs)
ES (1) ES2001019A6 (cs)
FI (1) FI89921C (cs)
GR (1) GR861866B (cs)
HU (1) HU198486B (cs)
IE (1) IE59025B1 (cs)
IL (1) IL79457A0 (cs)
LT (1) LT3869B (cs)
LV (1) LV5703A3 (cs)
MA (1) MA20739A1 (cs)
MX (1) MX9254A (cs)
NO (1) NO165803C (cs)
NZ (1) NZ216888A (cs)
OA (1) OA08707A (cs)
PH (1) PH26262A (cs)
PT (1) PT83013B (cs)
RU (1) RU2051918C1 (cs)
TN (1) TNSN86111A1 (cs)
WO (1) WO1987000523A2 (cs)
ZA (1) ZA865374B (cs)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
US5338741A (en) * 1986-10-27 1994-08-16 Nestec S.A. 1-hydroxyalkylxanthines and medicaments containing them
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
IT1240843B (it) * 1990-05-24 1993-12-17 Malesci Istituto Farmacobiologico Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione.
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
US5039666A (en) * 1990-10-30 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside
DE69119700T2 (de) * 1990-11-07 1996-11-07 Hoechst Roussel Pharma Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
TW209834B (cs) * 1991-12-11 1993-07-21 Hoechst Ag
ES2096115T3 (es) * 1992-02-22 1997-03-01 Hoechst Ag Uso de derivados de xantina para el tratamiento de lesiones musculares despues de la interrupcion completa de la circulacion sanguinea.
DE69332634T2 (de) * 1992-03-04 2003-05-08 Cell Therapeutics, Inc. Enantiomere hydroxylierte xanthinverbindungen
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5288721A (en) * 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US5473070A (en) * 1992-11-16 1995-12-05 Cell Therapeutics, Inc. Substituted long chain alcohol xanthine compounds
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
US6693105B1 (en) 1992-11-16 2004-02-17 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US5866576A (en) * 1992-12-16 1999-02-02 Cell Therapeutics, Inc. Epoxide-containing compounds
WO1994015605A1 (en) * 1993-01-14 1994-07-21 Cell Therapeutics, Inc. Acetal or ketal substituted therapeutic compounds
WO1994016704A1 (en) * 1993-01-19 1994-08-04 Cell Therapeutics, Inc. Oxime-substituted therapeutic compounds
US5837703A (en) * 1993-03-31 1998-11-17 Cell Therapeutics, Inc. Amino-alcohol substituted cyclic compounds
US5641783A (en) * 1993-11-12 1997-06-24 Cell Therapeutics, Inc. Substituted amino alcohol compounds
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
WO1995019171A1 (en) * 1994-01-14 1995-07-20 Cell Therapeutics, Inc. Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
CA2183562A1 (en) * 1994-02-18 1995-08-24 J. Peter Klein Intracellular signalling mediators
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel
US5965555A (en) * 1996-06-07 1999-10-12 Hoechst Aktiengesellschaft Xanthine compounds having terminally animated alkynol side chains
DK0812844T3 (da) * 1996-06-07 2003-02-17 Hoechst Ag Anvendelse af theophyllinderivater til behandling og profylakse af choktilstande, nye xanthinforbindelser og fremgangsmåder til deres fremstilling
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US5985592A (en) * 1997-06-05 1999-11-16 Dalhousie University Uses for pentoxifylline or functional derivatives/metabolites thereof
US6294350B1 (en) 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
US6075029A (en) * 1998-01-02 2000-06-13 Cell Therapeutics, Inc. Xanthine modulators of metabolism of cellular P-450
US20030207901A1 (en) * 1999-07-27 2003-11-06 Cell Therapeutics, Inc. Hydroxyl-containing compounds
RU2157209C1 (ru) * 2000-03-23 2000-10-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Улучшающее мозговое кровообращение, антиагрегатное средство и способ его получения
DE10042152A1 (de) * 2000-08-26 2002-03-28 Basf Coatings Ag Mit aktinischer Strahlung aktivierbares Thixotropierungsmittel, Verfahren zu seiner Herstellung und seine Verwendung
DE10122390A1 (de) * 2001-05-09 2002-11-28 Basf Coatings Ag Carbamat-und/oder Allophanatgruppen enthaltende, thermisch härtbare, thixotrope Gemische
DE10139262C1 (de) * 2001-08-09 2003-01-02 Basf Coatings Ag Rheologiehilfsmittel, Verfahren zu seiner Herstellung und seine Verwendung
WO2003091350A1 (de) * 2002-04-24 2003-11-06 Basf Coatings Ag Carbamat- und/oder allophanatgruppen enthaltende, thermisch härtbare, thixotrope gemische
KR100872788B1 (ko) * 2002-05-28 2008-12-09 엘지전자 주식회사 드럼세탁기
US8686090B2 (en) * 2003-12-10 2014-04-01 Basf Coatings Gmbh Use of urea crystals for non-polymeric coatings
US20080081816A1 (en) * 2006-10-03 2008-04-03 Kaohsiung Medical University Anti-inflammation activity of newly synthesized xanthine derivatives kmup-1 and kmup-3
CA2716788C (en) 2008-02-29 2016-08-16 Concert Pharmaceuticals, Inc. Deuterium-substituted xanthine derivatives
KR20110014974A (ko) * 2008-03-31 2011-02-14 썬 파마슈티컬 인더스트리스 리미티드 모르피난 유사체의 개선된 제조 방법
US8952016B2 (en) 2009-02-27 2015-02-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US8263601B2 (en) 2009-02-27 2012-09-11 Concert Pharmaceuticals, Inc. Deuterium substituted xanthine derivatives
WO2011028820A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
WO2012031072A1 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
WO2012031073A1 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
KR20150002779A (ko) 2012-04-13 2015-01-07 콘서트 파마슈티컬즈, 인크. 치환된 크산틴 유도체

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE2335170C2 (de) * 1973-07-11 1989-07-20 Hoechst Ag, 6230 Frankfurt 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4576947A (en) * 1967-12-16 1986-03-18 Hoechst Aktiengesellschaft Pharmaceutical compositions
BE795345A (fr) * 1972-02-19 1973-08-13 Albert Ag Chem Werke MEDICAMENT UTILE NOTAMMENT POUR L'IRRIGATION CEREBRALE, PROCEDE DE PREPARATION DE SES MATIERES ACTIVES ET CES MATIERES ElLES-MEMES
CH622519A5 (en) * 1974-07-05 1981-04-15 Hoechst Ag Process for the preparation of hydroxyalkylxanthines
DE2432702C2 (de) * 1974-07-08 1983-01-20 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von Hydroxyalkylxanthinen
CA1075690A (en) * 1974-12-13 1980-04-15 Hoechst Aktiengesellschaft Xanthine derivatives
DE3062499D1 (en) * 1979-04-05 1983-05-05 Beecham Wuelfing Gmbh & Co Kg Dialkoxy- and dioxacycloalkyl-alkyltheobromines, pharmaceutical compositions containing them and their preparation
JPS5838284A (ja) * 1981-09-01 1983-03-05 Teikoku Chem Ind Corp Ltd １−（５′−オキソヘキシル）−３，７−ジメチルキサンチンの製造方法
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4575795A (en) * 1983-04-01 1986-03-11 Honeywell Information Systems Inc. Apparatus for detecting a predetermined character of a data string

Also Published As

Publication number Publication date
NO165803B (no) 1991-01-02
DD261156A5 (de) 1988-10-19
MA20739A1 (fr) 1987-04-01
EP0268585A1 (de) 1988-06-01
LT3869B (en) 1996-04-25
IL79457A0 (en) 1986-10-31
CA1262248A (en) 1989-10-10
FI880174A0 (fi) 1988-01-15
DE3671627D1 (de) 1990-07-05
HU198486B (en) 1989-10-30
HUT47274A (en) 1989-02-28
RU2051918C1 (ru) 1996-01-10
OA08707A (en) 1989-03-31
FI89921C (fi) 1993-12-10
IE861917L (en) 1987-01-19
DK139287D0 (da) 1987-03-18
LTIP1467A (en) 1995-05-25
JPS63501149A (ja) 1988-04-28
AR244689A1 (es) 1993-11-30
DK139287A (da) 1987-03-18
PH26262A (en) 1992-04-01
CS272766B2 (en) 1991-02-12
NO165803C (no) 1991-04-10
CN1026112C (zh) 1994-10-05
NZ216888A (en) 1989-05-29
WO1987000523A3 (fr) 1987-02-26
NO871111D0 (no) 1987-03-18
BG60767B2 (bg) 1996-02-29
LV5703A3 (lv) 1995-02-20
FI89921B (fi) 1993-08-31
KR870700623A (ko) 1987-12-30
WO1987000523A2 (en) 1987-01-29
DK157867B (da) 1990-02-26
NO871111L (no) 1987-03-18
IE59025B1 (en) 1993-12-15
GR861866B (en) 1986-11-17
FI880174L (fi) 1988-01-15
AU6143986A (en) 1987-02-10
US4833146A (en) 1989-05-23
DK157867C (da) 1990-07-30
KR950001019B1 (ko) 1995-02-07
DE3525801A1 (de) 1987-01-22
ES2001019A6 (es) 1988-04-16
PT83013A (de) 1986-08-01
TNSN86111A1 (fr) 1990-01-01
MX9254A (es) 1993-06-01
JPH0788382B2 (ja) 1995-09-27
CN86105835A (zh) 1987-01-14
ATE53211T1 (de) 1990-06-15
PT83013B (pt) 1989-01-30
EP0268585B1 (de) 1990-05-30
AU588350B2 (en) 1989-09-14
ZA865374B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
CS545386A2 (en) Method of tertiary hydroxyalkylxanthine production
HUT45096A (en) Process for production of l-lisine
PL260784A1 (en) The method of production of new hydroxy- and- alkoxypirimidine
CS837985A2 (en) Method of isosilybine-free silybine production
CS287386A2 (en) Method of silyl-enol ethers production
CS988386A2 (en) Method of azoniaspironortropanol esters production
PL261404A1 (en) A method of 3-azidenucleosides production
CS960386A2 (en) Method of substituted benzamides production
GB8512500D0 (en) Production of bodies-building elements
CS850787A2 (en) Method of substituted 1-phenoxy-3-amino-2-propanols production
CS407186A1 (en) Method of paper production
CS415888A2 (en) Method of new acylderivatives production
CS591188A2 (en) Method of spiroimidazolidinedione production
CS548787A2 (en) Method of new tetrahydrobenzothiazolo-quinolines production
CS686987A2 (en) Method of new 1-aryloxy-dihydrobenzothiadiazinyl alkylamino-alkanes production
CS272207B2 (en) Method of chanoclavine production
CS921285A2 (en) Method of carbasates production
SU1374491A1 (ru) Cпocoб пoлучehия диaгhoctиkуma
CS200889A2 (en) Method of tertiary hydroxyalkylxantine production
GB8729133D0 (en) Method for production of 1-valine
CS105389A2 (en) Method of 4-benzyloxy-3-pyrroline-2-on-1-yl-acetamide production
CS251586A1 (en) Method of crotonolactone production
CS391985A2 (en) Method of alpha-ergocryptine production
SU1293182A1 (ru) "cпocoб пoлучehия -kaпpoлaktoha"
SU1407016A1 (ru) Cпocoб пoлучehия пoлиamидoбehзиmидaзoлob